23rd World Congress on Advances in Oncology
and
22nd International Symposium on Molecular Medicine

September 20-22, 2018
The New Metropolitan Hotel, Athens, Greece
The list is incomplete and will be updated periodically:



Acevedo-Duncan Mildred
 - (USA) - Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide (ICA-1); a potent Protein kinase C-ι inhibitor as a potential anticancer drug..
Asuthkar Swapna
 - (USA) - Targeting B7H3 in medulloblastoma tumor vasculature.

Balcerczak Ewa
 - (Poland) - The role of selected ABC family genes in bilateral breast cancer cases.

Botelho Monica
 - (Portugal) - Estrogen metabolism in Schistosoma haematobium-associated bladder cancer.

Bravou Vasiliki
 - (Greece) - Crosstalk between the IPP complex and oncogenic KRAS in lung cancer.

Cava Claudia
 - (Italy) - miRNAs regulating pathways cross-talk in breast cancer subtypes.

Dalianis Tina
 - (Sweden) - Changes in human papilloma virus (HPV) prevalence in genital and oral samples in some groups of youth in Sweden during the introduction of the HPV vaccine.

Danilenko Michael
 - (Israel) - Synergistically acting combinations of natural phenolic compounds for the treatment of acute myeloid leukemia.

Gondi Christopher
 - (USA) - Circular dumbbell RNAs loaded with miR34a: a novel anti angiogenic approach.

Grzybowska-Szatkowska Ludmila
 - (Poland) - Polymorphisms in mtDNA in the brain tumor .

Guo Hongfeng
 - (China) - Family haploidentical donor-derived cytokine-induced killer cells biotherapy combined with bortezomib in two relapsed patients with multiple myeloma in a non-allogeneic transplant setting.

Guo Hongfeng
 - (China) - Evaluation of neutrophil-to-lymphocyte ratio in newly diagnosed patients receiving bortezomib-based therapy for multiple myeloma.

Gyorffy Balazs
 - (Hungary) - Molecular markers of therapy response in breast cancer.

Karagiannis Sophia
 - (UK) - Novel antibody strategies for breast cancer.

Katsantoni Eleni
 - (Greece) - STAT5 transcriptional networks: Towards biomarkers discovery.

Katsuta Eriko
 - (USA) - High expression of H2AX predict early recurrence in advanced stage breast cancer.

Liu Hongxing
 - (China) - CSF3R Mutations Are Frequently Associated with Abnormalities of RUNX1, CBFB, CEBPA, and NPM1 Genes in Acute Myeloid Leukemia.

Nikitovic Dragana
 - (Greece) - The roles of hyaluronan/RHAMM and their respective interactions along the insidious pathways of fibrosarcoma progression.

Osawa Hiroshi
 - (Japan) - Efficacy and safety of TAS-102 plus Bevacizumab for patients with metastatic colorectal cancer in salvage line.

Pissas George
 - (Greece) - Facing endoplasmic reticulum stress-induced damage.

Salerno Loredana
 - (Italy) - Imidazole-based heme oxygenase-1 inhibitors to improve cancer therapy.

Sorrenti Valeria
 - (Italy) - Heme Oxygenase-1 Inhibitors to Overcome Imatinib Resistance in Chronic Myeloid Leukemia.

Telang Nitin
 - (USA) - Drug resistant breast and colon cancer stem cells: Targeted approach for stem cell therapy.

Veisi Kamal
 - (Iran) - Solubility improved germline-humanized anti-EGFR single chain antibody.

Wang Ke
 - (China) - Inhibitory effects of BMP9  on the bone metastasis of breast cancer cells by adipose and bone  microenvironment.

Wang Zheng
 - (China) - Main Driver Mutations Shape Clinically Relevant Genomic Clusters of Intrahepatic Cholangiocarcinoma with Distinct Molecular Features and Novel Prognostic Capabilities.

Yanatatsaneejit Pattamawadee
 - (Thailand) - E6 and E7 HPV induce DAPK1 and CADM1 promoter methylation in cervical cancer.

Youness Rana Ahmed
 - (Egypt) - Shedding the light onto the potential role of Hydrogen sulphide in Breast Cancer.

Juhua Zhou
 - (China) - Clinical applications of tumor-infiltrating lymphocytes in cancer adoptive immunotherapy.




Back to Top